Eller har de tatt vinterferie og sprader rundt i skiløypa med kakao i sekken…?
Det som provoserer meg litt fra meldingene 4 og 11 oktober er at jeg ble lurt til å tro at de ville ha kapital frem til juni… så tok det helt med ro vel vitende om at SWIS kunne få 510k godkjenning når som helst og SIS fase 2 design var under utarbeidelse (ble sagt denne ville være klar i slutten av året, men “kan skli noe inn i 2023”). Plutselig er kassen tom såvidt inn i det nye året…
4 oktober
“On the basis of this plan, the company estimates that a cash injection of up to NOK 50 million is sufficient to fund the company to June 2023. An underwritten rights issue is one of the alternatives being evaluated. The estimated capital need does not take into account that approximately NOK 25 million of the previous announced grants on the SoftOx inhalation solution (SIS) is expected to be pre-paid at the time of signing the research agreement (as SoftOx is defined as a SMB company).”
11 oktober
"The total proceeds of the new loan will be NOK 40 million and have due date 15 January 2024.
Together with the previously announced grants on the SoftOx inhalation solutions (SIS), the new loan will secure the Company a liquidity injection of up to a total amount of NOK 50 million. Payment of the funds under the SIS grant is subject to signing the final contract.
Continued pursuit of strategic solutions and partnerships
The new loan will give SoftOx time to deliver on previously announced target milestones over the next 6-9 months."
Men jeg ble vel lurt siden de først ikke tok med EDF i melding 4 oktober, for så å regne med den 11 oktober?